Pixelgen Technologies
Sweden · Biotech · Healthtech · Enterprise software
Pixelgen Technologies develops laboratory assays and software that map how proteins are arranged on the surfaces of individual cells.
Product
Pixelgen Technologies helps life-sciences researchers study how proteins are organised on individual cell surfaces. Its Proxiome Kit uses the Proximity Network Assay to map protein location and clustering at nanoscale resolution, adding information about cell architecture to conventional measurements of protein abundance.
Researchers can use these maps to investigate cell function, disease mechanisms and responses to treatment. Pixelgen pairs the laboratory kit with data-analysis and visualisation software, serving applications across immunology, oncology, haematology and cell therapy. The Stockholm company is expanding international commercial access to the platform.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $15.5M | Flat Capital — Role not disclosedIndustrifonden — Role not disclosedNavigare Ventures — Role not disclosed |